Caroline Seymour

Managing Editor, OncLive®
Caroline Seymour is your initial point of contact for the OncLive® podcast, OncLive On Air™. She joined the company in 2018 as an assistant editor, with expertise in video production and print/digital publication. Email: cseymour@onclive.com

Articles

Updates Continue in Oncogene-Driven Lung Cancer

August 16th 2018

Jose M. Pacheco, MD, discusses the preferred therapeutic strategies for treating patients with NSCLC whose tumors harbor genetic alterations in EGFR, ALK, and ROS1.

Expert Explains Work Needed for Immunotherapy/RT Approaches in NSCLC

August 15th 2018

James Larner, MD, discusses the process by which radiation interacts with the immune system and how physicians are working to improve treatment responses for patients with non–small cell lung cancer.

Barr Bridges Past and Present Treatment of Neuroendocrine Tumors

August 15th 2018

Jodie Barr, DO, discusses the evolution of treatment of patients with neuroendocrine tumors and the need for biomarkers.

Standards of Care Shifting in Early-Stage NSCLC

August 14th 2018

Alexander R. Menter, MD, discusses treatment advances in early-stage non–small cell lung cancer (NSCLC).

Tripathy Discusses Developments in HR+ Breast Cancer

August 14th 2018

Debu Tripathy, MD, discusses the evolution of treatment of patients with metastatic HR-positive breast cancer.

Expert Calls Screening to the Forefront in Lung Cancer

August 10th 2018

Robert M. Jotte, MD, PhD, addresses the underutilization of lung cancer screening in the United States and the importance of multidisciplinary management in improving patient outcomes.

Expert Reinforces Importance of Regional Nodal Irradiation in Breast Cancer

August 10th 2018

Wendy A. Woodward, MD, PhD, highlights encouraging advances and ongoing developments with radiotherapy in breast cancer.

Expert Explains Limitations of Molecular Profiling in Lung Cancer

August 10th 2018

Dara L. Aisner, MD, PhD, discusses the rapidly progressing field of molecular profiling, the importance of understanding assay results, and how they translate to patient care in lung cancer.

Patient-Reported Outcomes With Stem Cell Transplant Signal Progress in Myeloma

August 8th 2018

Noa Biran, MD, discusses patient-reported outcomes following autologous stem cell transplant in patients with myeloma.

Expert Shares Insight on Refinements in Breast Cancer Radiotherapy

August 8th 2018

Naamit K. Gerber, MD, discusses recent advances in radiation therapy in the field of breast cancer.

Expert Details Latest Data Across GI Cancers

August 7th 2018

Susanna Ulahannan, MD, highlights trials from the 2018 ASCO Annual Meeting across gastrointestinal malignancies and future therapeutic approaches across the landscape.

Talley Traces Developments in Chronic Leukemias

August 3rd 2018

Robert L. Talley, MD, elaborates on the clinical trial findings that are shifting standards of care in chronic leukemias.

Immunotherapy Remains Focal Point in TNBC

July 27th 2018

Sylvia Adams, MD, discusses the path forward for immunotherapy in triple-negative breast cancer.

Melanoma Field Continues to Shift With Targeted Therapy, Immunotherapy Approvals

July 26th 2018

Joseph Stilwill, MD, addresses recent advances in melanoma and the focus of research moving forward.

Regulatory Decisions Propel Nonmetastatic CRPC Paradigm Forward

July 26th 2018

Mehmood Hashmi, MD, discusses the newly defined landscape of nonmetastatic castration-resistant prostate cancer, the potential with immunotherapy, and emerging imaging modalities.

Targeted Therapies Emerging for Less-Common NSCLC Subtypes

July 25th 2018

Jessica Bauman, MD, addresses current and emerging therapeutic options for patients with BRAF, ROS1, and RET abnormalities in non–small cell lung cancer.

Biomarkers for Frontline Immunotherapy Pose Obstacles in NSCLC

July 25th 2018

John A. Kosteva, MD, discusses the adoption of immunotherapy into the treatment paradigm for patients with non–small cell lung cancer.

Novel Combinations Advance Through RCC Pipeline

July 20th 2018

Peter J. Van Veldhuizen, MD, discusses available and emerging therapies for patients with kidney cancer.

Expert Sees Biosimilars as Integral to Expanding Access, Controlling Costs in Oncology

July 17th 2018

Yelena Novik, MD, shares her thoughts on the use of biosimilars in oncology and their potential impact on practice.

Progress Continues in EGFR+ NSCLC Paradigm

July 16th 2018

Charu Aggarwal, MD, discusses the latest developments in EGFR-mutant lung cancer.